The US Food and Drug Administration (FDA) has finalizes the rule on the intent to amend the list of drug products in the country.
This final rule provides the following changes:
- Addition of 24 entries to the list of drug products
- Modification of description of one entry on this list
- Revision of the list's title and introductory language
The final rule was effective on November 7, 2016.